Megaloblastic Anemia

Definition

Megaloblastic anemia results from impaired DNA synthesis due to vitamin B12 or folate deficiency, causing the production of abnormally large, immature red blood cells.

How it works

Megaloblastic anemia occurs when deficiencies in vitamin B12 (cobalamin) or folate impair the DNA replication required for normal red blood cell maturation. This results in the production of fewer but larger immature red blood cells (megaloblasts) that are fragile and ineffective at oxygen transport. Vitamin B12 is essential for methionine synthesis and myelin formation, while folate is crucial for nucleotide synthesis. Common causes include pernicious anemia (B12), dietary insufficiency (vegetarian diets lacking B12), gastrointestinal malabsorption, and methotrexate use (folate antagonist). Symptoms include fatigue, neurological manifestations (with B12 deficiency), and glossitis.

Role

B12 and folate deficiencies impair DNA synthesis, resulting in abnormal red blood cell maturation and reduced oxygen-carrying capacity.

Examples

• Pernicious anemia from intrinsic factor deficiency
• Folate deficiency in pregnant women
• B12 deficiency in strict vegans
• Methotrexate-induced folate deficiency in cancer patients

Recommendations

Diagnose the specific deficiency (B12 vs. folate) through serum and methylmalonic acid testing. Supplement with cyanocobalamin (B12) via injections or high-dose oral supplements, and folic acid or methylfolate for folate deficiency. Include B12-rich foods (animal products, fortified cereals) or folate-rich foods (leafy greens, legumes) depending on the deficiency type.

Key takeaway

Megaloblastic anemia requires specific supplementation with vitamin B12 or folate based on the underlying deficiency.

Related terms